Abstract 32 Low Incidence of Product Complaints and Adverse Events Support Safety of Cord Blood Units

INTRODUCTION: As an important cellular therapy source for many patients, the safe and timely delivery of cord blood units (CBU) is paramount. The National Marrow Donor Program (NMDP) investigates product complaints received for CBUs distributed under the 10-CBA investigational new drug application t...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Gara, Erin, Regan, Donna, Rice, Lindsay, Bakken, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cord Blood Bank Management, Administration, and Sustainability
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446952/
http://dx.doi.org/10.1093/stcltm/szac057.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446952/
http://dx.doi.org/10.1093/stcltm/szac057.032

Ejemplares similares